Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cadence presents positive top-line results from phase III Acetavance trial

Dec. 23, 2008

Neurobiological Technologies terminates further enrollment in clinical trials of Viprinex

Dec. 22, 2008

Bionomics successfully completes safety studies in animals of antianxiety drug BNC-210

Dec. 22, 2008

KeyNeurotek completes patient recruitment in phase IIa study of KN38-7271 in TBI

Dec. 22, 2008

New agents for psychiatric disorders described in recent Lilly and NeuroSearch patents

Dec. 19, 2008

Recent patents divulge novel analgesic agents

Dec. 19, 2008

Lundbeck initiates phase III trials with desmoteplase in ischemic stroke

Dec. 19, 2008

FDA accepts Transcept's Intermezzo NDA for review

Dec. 19, 2008

Adlea significantly reduces pain after total knee replacement in phase III trial

Dec. 19, 2008

Novel analgesic agents imparted in recent patent literature

Dec. 18, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
In the clinic for July 17, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: AMT, Innocare, Insmed, Syntis, Telo Genomics.